Tularemia: Study of 27 patients;Tularemia: Análisis de 27 casos

Medicina Clinica

Volumn 119, Issue 12, 2002, Pages 455-457

  González Quijada, Santiago ^a   Rubió Díaz, Mayte ^a   Yánez Ortega, José Luis ^a   Carramiñana Martínez, Isabel ^a   Ojeda Fernández, Eva ^a   Lozano García, Javier ^a  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Clinical analysis; Tularemia

Indexed keywords

ADULT; AGED; ANIMAL HUNTING; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ERYTHEMA NODOSUM; FEMALE; FEVER; FOLLOW UP; HARE; HUMAN; LYMPH NODE HYPERPLASIA; LYMPHADENOPATHY; MALE; MORBIDITY; QUESTIONNAIRE; RELAPSE; SKIN DEFECT; SPAIN; TELEPHONE; TULAREMIA;

EID: 0037069152     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)73454-4     Document Type: Article

References (16)

1. a ed. Buenos Aires: Editorial Médica Panamericana, 1997; p. 2308-17.
2. Evans ME, Gregory DW, Scheffner W, McGee ZA. Tularemia: a 30-year experience with 88 cases. Medicine 1985;64:251-6.
3. Ohara Y, Sato T, Homa M. Arthopod-borne tularemia in Japan: clinical analysis of 1374 cases observed between 1924 and 1996. J Med Entomol 1998;35:471-3.
4. Bachiller P, Pérez L, Martin M, Mena FJ, De la Lama J, Pérez P, et al. Descripción preliminar de un brote epidémico de tularemia en Valladolid. Rev Clin Esp 1998;198:789-93.
5. Andrés C, Mateos L, Burón I, González MJ, Rebollo C, Sangrador LA. Brote epidémico de tularemia en Palencia. Rev Clin Esp 1999;711-5.
6. Dueñas AI, Ortega M, Garrote I, de Frutos M, Gutiérrez P, García-Pascual A, et al. Diagnóstico de laboratorio y evolución serológica de pacientes con tularemia. Med Clin (Barc) 2000;114: 407-10.
7. Montejo M, Pérez-Irezabal J, González P, Aguirrebengoa K, Vicente JM, Martínez E, et al. Tularemia: descripción de 16 cases procedentes de la Comunicad de Castilla-León. Rev Clin Esp 1998; 198:794-8.
8. Center of Disease Control. Team: tularemia case review. MMWR 1997;46(RR-10):53-4.
9. Benlyazid A, Lescanne E, Borderon JC, Ployet MJ. Cervicofacial manifestations of tularemia. Apropos of a familial case. Ann Otolaryngol Chir Cervicofac 1997;114:80-3.
10. Gurycova D, Vyrostekova V, Khanakah G, Kocianova E, Stanek G. Importance of surveillance of tularemia natural foci in the known endemic area of Central Europe. Wien Klin Wochenschr 2001;113:433-8.
11. Everett ED, Templer JW. Oropharyngeal tularemia. Arch Otolaryngol 1980;106:237-40.
12. Syrjälä H, Karvonen J, Salminen A. Skin manifestations of tularemia: a study of 88 cases in Northern Finland during 16 years (1967-1983). Acta Derm Venerol 1984;64:513-6.
13. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative for the treatment of tularemia: review of literature. Clin Infect Dis 1994;19:42-7.
14. Russell P, Eley SM, Fulop MJ, Bell DL, Titball RW. The efficacy of ciprofloxacin and doxicycline against experimental tularemia. J Antimicrob Chemother 1998;41:461-4.
15. Di Ninno VL, Cherwanogrodzky JW, Wong JP. Liposome-encapsulated ciprofloxacin is effective in the protection and treatment of BALB/c mice against Francisella tularensis. J Infect Dis 1993; 168:793-4.
16. Penn RL, Kinasewitz GT. Factors associated with a poor clinical outcome in tularemia. Arch Intern Med 1987;147:265-8.